Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in from biologics discovery and development through to production and supply chain management.

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Vaccines

China Warns of New Virus Transmitted by Shrews

How worrying is the new ‘Langya’ virus spreading in China?
Read More
Vaccines

Monkeypox Cases in UK Begin to Plateau

Statistics show that the number of people infected with the monkeypox virus is starting to slow down.
Read More
Proteins & Antibodies

AstraZeneca Suffers Sales Decline for COVID Med Evusheld

A 24 million loss has been reported for the preventative COVID-19 treatment.
Read More
Proteins & Antibodies

Market Battle for Rare Disease Treatment

Argenx and AstraZeneca are set to become market rivals in their general myasthenia gravis (gMG) treatments, analysts claim.
Read More
Bispecifics

Bispecific Antibodies for Solid Tumours

Laura von Schantz, Vice President of Discovery at Alligator Bioscience, leads a discussion on the current and future opportunities of bispecific antibodies for solid tumour treatment.
Read More
Vaccines

European Approval for Monkeypox Vaccine

The European Commission (EC) has approved Bavarian Nordic’s Imvanex vaccine which protects against monkeypox, and diseases caused by the vaccinia virus.
Read More
Vaccines

Discussion Group Announcement

Oxford Global’s next round of Biologics Discussion Groups announced.
Read More
Proteins & Antibodies

Widening the Therapeutic Window: Development of Antibody Drug Conjugates for Solid Tumours

Compared to non-solid tumours, solid tumours are more difficult to treat with conventional therapeutic methods. Antibody drug conjugates – biopharmaceutical drugs designed as a targeted therapy for treating cancer – represent a viable treatment alternative.
Read More
Proteins & Antibodies

Novartis Withdraws Tislelizumab Submission

Novartis scraps US submission of tislelizumab as a monotherapy for non-small cell lung cancer.
Read More
Vaccines

New Speakers Announced: Vaccines Europe Congress 2022

Exciting updates revealed about upcoming Vaccines Europe: In-Person congress happening 29-30 November 2022.
Read More
Proteins & Antibodies

Blood Test Predicts Presence of Beta-Amyloid in Brain

A study by the National Institute of Ageing found that a new blood test can accurately predict the presence of beta-amyloid plaques in the brain.
Read More
Vaccines

US Doubles its Supply of Monkeypox Vaccines

The US government has more than doubled its supply of Monkeypox vaccines amidst rising fears.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biologics